Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 235

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Role of omega-3 fatty acids and their metabolites in asthma and allergic diseases

Open access
Miyata, Jun, Arita, Makoto · 2015 · Allergology International

Abstract

Omega-3 fatty acids, docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), are found naturally in fish oil and are commonly thought to be anti-inflammatory nutrients, with protective effects in inflammatory diseases including asthma and allergies. The mechanisms of these effects remain mostly unknown but are of great interest for their potential therapeutic applications. Large numbers of epidemiological and observational studies investigating the effect of fish intake or omega-3 fatty acid supplementation during pregnancy, lactation, infancy, childhood, and adulthood on asthmatic and allergic outcomes have been conducted. They mostly indicate protective effects and suggest a causal relationship between decreased intake of fish oil in modernized diets and an increasing number of individuals with asthma or other allergic diseases. Specialized pro-resolving mediators (SPM: protectins, resolvins, and maresins) are generated from omega-3 fatty acids such as EPA and DHA via several enzymatic reactions. These mediators counter-regulate airway eosinophilic inflammation and promote the resolution of inflammation in vivo. Several reports have indicated that the biosynthesis of SPM is impaired, especially in severe asthma, which suggests that chronic inflammation in the lung might result from a resolution defect. This article focuses on the beneficial aspects of omega-3 fatty acids and offers recent insights into their bioactive metabolites including resolvins and protectins.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.alit.2014.08.003

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Research works printed but not linked: 105

  1. Saravanan, 2010, Cardiovascular effects of marine omega-3 fatty acids, Lancet, 376, 540, 10.1016/S0140-6736(10)60445-X · DOI · Paper page
  2. Calder, 2013, Omega-3 polyunsaturated fatty acids and inflammatory processes: nutrition or pharmacology?, Br J Clin Pharmacol, 75, 645, 10.1111/j.1365-2125.2012.04374.x · DOI · Paper page
  3. Yates, 2014, Pharmacology and therapeutics of omega-3 polyunsaturated fatty acids in chronic inflammatory disease, Pharmacol Ther, 141, 272, 10.1016/j.pharmthera.2013.10.010 · DOI · Paper page
  4. Miles, 2014, Omega-6 and omega-3 polyunsaturated fatty acids and allergic diseases in infancy and childhood, Curr Pharm Des, 20, 946, 10.2174/138161282006140220125732 · DOI
  5. Laidlaw, 2012, Cysteinyl leukotriene receptors, old and new; implications for asthma, Clin Exp Allergy, 42, 1313, 10.1111/j.1365-2222.2012.03982.x · DOI
  6. Wenzel, 1997, Arachidonic acid metabolites: mediators of inflammation in asthma, Pharmacotherapy, 17, 10.1002/j.1875-9114.1997.tb03696.x · DOI
  7. Braman, 2006, The global burden of asthma, Chest, 130, 4S, 10.1378/chest.130.1_suppl.4S · DOI · Paper page
  8. Bell, 2013, Severe asthma: an expanding and mounting clinical challenge, J Allergy Clin Immunol Pract, 1, 110, 10.1016/j.jaip.2013.01.005 · DOI
  9. Planaguma, 2008, Airway lipoxin A4 generation and lipoxin A4 receptor expression are decreased in severe asthma, Am J Respir Crit Care Med, 178, 574, 10.1164/rccm.200801-061OC · DOI · Paper page
  10. Bhavsar, 2010, Corticosteroid suppression of lipoxin A4 and leukotriene B4 from alveolar macrophages in severe asthma, Respir Res, 11, 71, 10.1186/1465-9921-11-71 · DOI
  11. Kazani, 2013, Exhaled breath condensate eicosanoid levels associate with asthma and its severity, J Allergy Clin Immunol, 132, 547, 10.1016/j.jaci.2013.01.058 · DOI
  12. Fritscher, 2012, Profile of eicosanoids in breath condensate in asthma and COPD, J Breath Res, 6, 026001, 10.1088/1752-7155/6/2/026001 · DOI
  13. Levy, 2005, Diminished lipoxin biosynthesis in severe asthma, Am J Respir Crit Care Med, 172, 824, 10.1164/rccm.200410-1413OC · DOI · Paper page
  14. Celik, 2007, Lipoxin A4 levels in asthma: relation with disease severity and aspirin sensitivity, Clin Exp Allergy, 37, 1494, 10.1111/j.1365-2222.2007.02806.x · DOI
  15. Wu, 2010, Reversed changes of lipoxin A4 and leukotrienes in children with asthma in different severity degree, Pediatr Pulmonol, 45, 333, 10.1002/ppul.21186 · DOI
  16. Bonnans, 2002, Lipoxins are potential endogenous antiinflammatory mediators in asthma, Am J Respir Crit Care Med, 165, 1531, 10.1164/rccm.200201-053OC · DOI
  17. Vachier, 2005, Severe asthma is associated with a loss of LX4, an endogenous anti-inflammatory compound, J Allergy Clin Immunol, 115, 55, 10.1016/j.jaci.2004.09.038 · DOI
  18. Miyata, 2013, Dysregulated synthesis of protectin D1 in eosinophils from patients with severe asthma, J Allergy Clin Immunol, 131, 353, 10.1016/j.jaci.2012.07.048 · DOI
  19. Freedman, 2004, Association of cystic fibrosis with abnormalities in fatty acid metabolism, N Engl J Med, 350, 560, 10.1056/NEJMoa021218 · DOI · Paper page
  20. Calvani, 2006, Consumption of fish, butter and margarine during pregnancy and development of allergic sensitizations in the offspring: role of maternal atopy, Pediatr Allergy Immunol, 17, 94, 10.1111/j.1399-3038.2005.00367.x · DOI
  21. Romieu, 2007, Maternal fish intake during pregnancy and atopy and asthma in infancy, Clin Exp Allergy, 37, 518, 10.1111/j.1365-2222.2007.02685.x · DOI · Paper page
  22. Salam, 2005, Maternal fish consumption during pregnancy and risk of early childhood asthma, J Asthma, 42, 513, 10.1081/JAS-200067619 · doi:10.1081/jas-200067619
  23. Sausenthaler, 2007, Maternal diet during pregnancy in relation to eczema and allergic sensitization in the offspring at 2 y of age, Am J Clin Nutr, 85, 530, 10.1093/ajcn/85.2.530 · DOI · Paper page
  24. Willers, 2007, Maternal food consumption during pregnancy and asthma, respiratory and atopic symptoms in 5-year-old children, Thorax, 62, 773, 10.1136/thx.2006.074187 · DOI · Paper page
  25. Andreasyan, 2005, A differing pattern of association between dietary fish and allergen-specific subgroups of atopy, Allergy, 60, 671, 10.1111/j.1398-9995.2005.00757.x · DOI
  26. Antova, 2003, Nutrition and respiratory health in children in six Central and Eastern European countries, Thorax, 58, 231, 10.1136/thorax.58.3.231 · DOI
  27. Chatzi, 2007, Diet, wheeze, and atopy in school children in Menorca, Spain, Pediatr Allergy Immunol, 18, 480, 10.1111/j.1399-3038.2007.00596.x · DOI
  28. Dunder, 2001, Diet, serum fatty acids, and atopic diseases in childhood, Allergy, 56, 425, 10.1034/j.1398-9995.2001.056005425.x · DOI
  29. Hodge, 1996, Consumption of oily fish and childhood asthma risk, Med J Aust, 164, 137, 10.5694/j.1326-5377.1996.tb122010.x · DOI · Paper page
  30. Huang, 2001, Dietary factors associated with physician-diagnosed asthma and allergic rhinitis in teenagers: analyses of the first Nutrition and Health Survey in Taiwan, Clin Exp Allergy, 31, 259, 10.1046/j.1365-2222.2001.00938.x · DOI
  31. Kim, 2005, Current asthma and respiratory symptoms among pupils in relation to dietary factors and allergens in the school environment, Indoor Air, 15, 170, 10.1111/j.1600-0668.2005.00334.x · DOI
  32. Kull, 2006, Fish consumption during the first year of life and development of allergic diseases during childhood, Allergy, 61, 1009, 10.1111/j.1398-9995.2006.01115.x · DOI · Paper page
  33. Nafstad, 2003, Asthma and allergic rhinitis at 4 years of age in relation to fish consumption in infancy, J Asthma, 40, 343, 10.1081/JAS-120018633 · DOI
  34. Hoppu, 2005, Breast milk fatty acid composition is associated with development of atopic dermatitis in the infant, J Pediatr Gastroenterol Nutr, 41, 335, 10.1097/01.mpg.0000168992.44428.fa · DOI
  35. Barros, 2011, Dietary intake of alpha-linolenic acid and low ratio of n-6:n-3 PUFA are associated with decreased exhaled NO and improved asthma control, Br J Nutr, 106, 441, 10.1017/S0007114511000328 · DOI
  36. Broadfield, 2004, A case-control study of dietary and erythrocyte membrane fatty acids in asthma, Clin Exp Allergy, 34, 1232, 10.1111/j.1365-2222.2004.02032.x · DOI
  37. Burns, 2007, Low dietary nutrient intakes and respiratory health in adolescents, Chest, 132, 238, 10.1378/chest.07-0038 · DOI
  38. Kompauer, 2008, Association of fatty acids in serum phospholipids with lung function and bronchial hyperresponsiveness in adults, Eur J Epidemiol, 23, 175, 10.1007/s10654-007-9218-y · DOI
  39. Li, 2013, Intakes of long-chain omega-3 (n-3) PUFAs and fish in relation to incidence of asthma among American young adults: the CARDIA study, Am J Clin Nutr, 97, 173, 10.3945/ajcn.112.041145 · DOI
  40. McKeever, 2008, The relation between dietary intake of individual fatty acids, FEV1 and respiratory disease in Dutch adults, Thorax, 63, 208, 10.1136/thx.2007.090399 · DOI
  41. Woods, 2004, Fatty acid levels and risk of asthma in young adults, Thorax, 59, 105, 10.1136/thorax.2003.009498 · DOI
  42. Barden, 2004, Fish oil supplementation in pregnancy lowers F2-isoprostanes in neonates at high risk of atopy, Free Radic Res, 38, 233, 10.1080/10715760310001656722 · DOI
  43. Dunstan, 2007, The effects of fish oil supplementation in pregnancy on breast milk fatty acid composition over the course of lactation: a randomized controlled trial, Pediatr Res, 62, 689, 10.1203/PDR.0b013e318159a93a · DOI
  44. Dunstan, 2004, Effects of n-3 polyunsaturated fatty acid supplementation in pregnancy on maternal and fetal erythrocyte fatty acid composition, Eur J Clin Nutr, 58, 429, 10.1038/sj.ejcn.1601825 · DOI
  45. Dunstan, 2004, The effect of supplementation with fish oil during pregnancy on breast milk immunoglobulin A, soluble CD14, cytokine levels and fatty acid composition, Clin Exp Allergy, 34, 1237, 10.1111/j.1365-2222.2004.02028.x · DOI
  46. Krauss-Etschmann, 2007, Effects of fish-oil and folate supplementation of pregnant women on maternal and fetal plasma concentrations of docosahexaenoic acid and eicosapentaenoic acid: a European randomized multicenter trial, Am J Clin Nutr, 85, 1392, 10.1093/ajcn/85.5.1392 · DOI · Paper page
  47. Warstedt, 2009, The effects of omega-3 fatty acid supplementation in pregnancy on maternal eicosanoid, cytokine, and chemokine secretion, Pediatr Res, 66, 212, 10.1203/PDR.0b013e3181aabd1c · DOI
  48. Denburg, 2005, Fish oil supplementation in pregnancy modifies neonatal progenitors at birth in infants at risk of atopy, Pediatr Res, 57, 276, 10.1203/01.PDR.0000148279.72611.1D · DOI
  49. Dunstan, 2003, Fish oil supplementation in pregnancy modifies neonatal allergen-specific immune responses and clinical outcomes in infants at high risk of atopy: a randomized, controlled trial, J Allergy Clin Immunol, 112, 1178, 10.1016/j.jaci.2003.09.009 · DOI · Paper page
  50. Dunstan, 2003, Maternal fish oil supplementation in pregnancy reduces interleukin-13 levels in cord blood of infants at high risk of atopy, Clin Exp Allergy, 33, 442, 10.1046/j.1365-2222.2003.01590.x · DOI · Paper page
  51. Krauss-Etschmann, 2008, Decreased cord blood IL-4, IL-13, and CCR4 and increased TGF-beta levels after fish oil supplementation of pregnant women, J Allergy Clin Immunol, 121, 464, 10.1016/j.jaci.2007.09.018 · DOI · Paper page
  52. Lauritzen, 2005, Fish oil supplementation of lactating mothers affects cytokine production in 2 1/2-year-old children, Lipids, 40, 669, 10.1007/s11745-005-1429-6 · DOI
  53. Prescott, 2007, Maternal fish oil supplementation in pregnancy modifies neonatal leukotriene production by cord-blood-derived neutrophils, Clin Sci (Lond), 113, 409, 10.1042/CS20070111 · DOI
  54. Furuhjelm, 2009, Fish oil supplementation in pregnancy and lactation may decrease the risk of infant allergy, Acta Paediatr, 98, 1461, 10.1111/j.1651-2227.2009.01355.x · DOI · Paper page
  55. Olsen, 2008, Fish oil intake compared with olive oil intake in late pregnancy and asthma in the offspring: 16 y of registry-based follow-up from a randomized controlled trial, Am J Clin Nutr, 88, 167, 10.1093/ajcn/88.1.167 · DOI · Paper page
  56. Almqvist, 2007, Omega-3 and omega-6 fatty acid exposure from early life does not affect atopy and asthma at age 5 years, J Allergy Clin Immunol, 119, 1438, 10.1016/j.jaci.2007.01.046 · DOI
  57. Hodge, 1998, Effect of dietary intake of omega-3 and omega-6 fatty acids on severity of asthma in children, Eur Respir J, 11, 361, 10.1183/09031936.98.11020361 · DOI · Paper page
  58. Marks, 2006, Prevention of asthma during the first 5 years of life: a randomized controlled trial, J Allergy Clin Immunol, 118, 53, 10.1016/j.jaci.2006.04.004 · DOI · Paper page
  59. Mihrshahi, 2003, Eighteen-month outcomes of house dust mite avoidance and dietary fatty acid modification in the Childhood Asthma Prevention Study (CAPS), J Allergy Clin Immunol, 111, 162, 10.1067/mai.2003.36 · DOI · Paper page
  60. Peat, 2004, Three-year outcomes of dietary fatty acid modification and house dust mite reduction in the Childhood Asthma Prevention Study, J Allergy Clin Immunol, 114, 807, 10.1016/j.jaci.2004.06.057 · DOI · Paper page
  61. Damsgaard, 2007, Fish oil supplementation modulates immune function in healthy infants, J Nutr, 137, 1031
  62. Vaisman, 2005, The effect of fish oil supplementation on cytokine production in children, Eur Cytokine Netw, 16, 194
  63. Mihrshahi, 2004, Effect of omega-3 fatty acid concentrations in plasma on symptoms of asthma at 18 months of age, Pediatr Allergy Immunol, 15, 517, 10.1111/j.1399-3038.2004.00187.x · DOI
  64. Nagakura, 2000, Dietary supplementation with fish oil rich in omega-3 polyunsaturated fatty acids in children with bronchial asthma, Eur Respir J, 16, 861, 10.1183/09031936.00.16586100 · DOI · Paper page
  65. Emelyanov, 2002, Treatment of asthma with lipid extract of New Zealand green-lipped mussel: a randomised clinical trial, Eur Respir J, 20, 596, 10.1183/09031936.02.02632001 · DOI
  66. Mickleborough, 2006, Protective effect of fish oil supplementation on exercise-induced bronchoconstriction in asthma, Chest, 129, 39, 10.1378/chest.129.1.39 · DOI · Paper page
  67. Mickleborough, 2003, Fish oil supplementation reduces severity of exercise-induced bronchoconstriction in elite athletes, Am J Respir Crit Care Med, 168, 1181, 10.1164/rccm.200303-373OC · DOI · Paper page
  68. Schubert, 2009, Effect of n-3 polyunsaturated fatty acids in asthma after low-dose allergen challenge, Int Arch Allergy Immunol, 148, 321, 10.1159/000170386 · DOI
  69. Bilal, 2011, Fat-1 transgenic mice with elevated omega-3 fatty acids are protected from allergic airway responses, Biochim Biophys Acta, 1812, 1164, 10.1016/j.bbadis.2011.05.002 · DOI
  70. Morin, 2011, Docosahexaenoic acid derivative prevents inflammation and hyperreactivity in lung: implication of PKC-potentiated inhibitory protein for heterotrimeric myosin light chain phosphatase of 17 kD in asthma, Am J Respir Cell Mol Biol, 45, 366, 10.1165/rcmb.2010-0156OC · DOI
  71. Morin, 2013, MAG-EPA resolves lung inflammation in an allergic model of asthma, Clin Exp Allergy, 43, 1071, 10.1111/cea.12162 · DOI
  72. Yokoyama, 2000, Effect of aerosolized docosahexaenoic acid in a mouse model of atopic asthma, Int Arch Allergy Immunol, 123, 327, 10.1159/000053645 · DOI
  73. Schuster, 2014, Dietary long-chain omega-3 fatty acids do not diminish eosinophilic pulmonary inflammation in mice, Am J Respir Cell Mol Biol, 50, 626, 10.1165/rcmb.2013-0136OC · DOI
  74. Yin, 2009, Dietary supplementation of omega-3 fatty acid-containing fish oil suppresses F2-isoprostanes but enhances inflammatory cytokine response in a mouse model of ovalbumin-induced allergic lung inflammation, Free Radic Biol Med, 47, 622, 10.1016/j.freeradbiomed.2009.05.033 · DOI
  75. Buckley, 2014, Proresolving lipid mediators and mechanisms in the resolution of acute inflammation, Immunity, 40, 315, 10.1016/j.immuni.2014.02.009 · DOI · Paper page
  76. Yamada, 2011, Eosinophils promote resolution of acute peritonitis by producing proresolving mediators in mice, FASEB J, 25, 561, 10.1096/fj.10-170027 · DOI
  77. Isobe, 2013, Stereochemical assignment and anti-inflammatory properties of the omega-3 lipid mediator resolvin E3, J Biochem, 153, 355, 10.1093/jb/mvs151 · DOI
  78. Isobe, 2012, Identification and structure determination of novel anti-inflammatory mediator resolvin E3, 17,18-dihydroxyeicosapentaenoic acid, J Biol Chem, 287, 10525, 10.1074/jbc.M112.340612 · DOI · Paper page
  79. Kubota, 2014, Eicosapentaenoic acid is converted via omega-3 epoxygenation to the anti-inflammatory metabolite 12-hydroxy-17,18-epoxyeicosatetraenoic acid, FASEB J, 28, 586, 10.1096/fj.13-236224 · DOI
  80. Chiang, 2006, The lipoxin receptor ALX: potent ligand-specific and stereoselective actions in vivo, Pharmacol Rev, 58, 463, 10.1124/pr.58.3.4 · DOI · Paper page
  81. Marcheselli, 2010, Neuroprotectin D1/protectin D1 stereoselective and specific binding with human retinal pigment epithelial cells and neutrophils, Prostagl Leukot Essent Fat Acids, 82, 27, 10.1016/j.plefa.2009.10.010 · DOI
  82. Krishnamoorthy, 2010, Resolvin D1 binds human phagocytes with evidence for proresolving receptors, Proc Natl Acad Sci U S A, 107, 1660, 10.1073/pnas.0907342107 · DOI · Paper page
  83. Dalli, 2013, Resolvin D3 and aspirin-triggered resolvin D3 are potent immunoresolvents, Chem Biol, 20, 188, 10.1016/j.chembiol.2012.11.010 · DOI · Paper page
  84. Arita, 2005, Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1, J Exp Med, 201, 713, 10.1084/jem.20042031 · DOI · Paper page
  85. Arita, 2007, Resolvin E1 selectively interacts with leukotriene B4 receptor BLT1 and ChemR23 to regulate inflammation, J Immunol, 178, 3912, 10.4049/jimmunol.178.6.3912 · DOI · Paper page
  86. Schwab, 2007, Resolvin E1 and protectin D1 activate inflammation-resolution programmes, Nature, 447, 869, 10.1038/nature05877 · DOI · Paper page
  87. Levy, 2007, Protectin D1 is generated in asthma and dampens airway inflammation and hyperresponsiveness, J Immunol, 178, 496, 10.4049/jimmunol.178.1.496 · DOI · Paper page
  88. Camateros, 2007, Chronic asthma-induced airway remodeling is prevented by toll-like receptor-7/8 ligand S28463, Am J Respir Crit Care Med, 175, 1241, 10.1164/rccm.200701-054OC · DOI
  89. Grela, 2011, The TLR7 agonist R848 alleviates allergic inflammation by targeting invariant NKT cells to produce IFN-gamma, J Immunol, 186, 284, 10.4049/jimmunol.1001348 · DOI
  90. Xirakia, 2010, Toll-like receptor 7-triggered immune response in the lung mediates acute and long-lasting suppression of experimental asthma, Am J Respir Crit Care Med, 181, 1207, 10.1164/rccm.200908-1255OC · DOI
  91. Koltsida, 2013, Toll-like receptor 7 stimulates production of specialized pro-resolving lipid mediators and promotes resolution of airway inflammation, EMBO Mol Med, 5, 762, 10.1002/emmm.201201891 · DOI
  92. Levy, 2012, Resolvin D1 and resolvin E1 promote the resolution of allergic airway inflammation via shared and distinct olecular counter-regulatory pathways, Front Immunol, 3, 390, 10.3389/fimmu.2012.00390 · DOI
  93. Rogerio, 2012, Resolvin D1 and aspirin-triggered resolvin D1 promote resolution of allergic airways responses, J Immunol, 189, 1983, 10.4049/jimmunol.1101665 · DOI · Paper page
  94. Aoki, 2008, Resolvin E1 dampens airway inflammation and hyperresponsiveness in a murine model of asthma, Biochem Biophys Res Commun, 367, 509, 10.1016/j.bbrc.2008.01.012 · DOI · Paper page
  95. Aoki, 2010, Protective effect of resolvin E1 on the development of asthmatic airway inflammation, Biochem Biophys Res Commun, 400, 128, 10.1016/j.bbrc.2010.08.025 · DOI
  96. Haworth, 2011, NK cells are effectors for resolvin E1 in the timely resolution of allergic airway inflammation, J Immunol, 186, 6129, 10.4049/jimmunol.1004007 · DOI
  97. Haworth, 2008, Resolvin E1 regulates interleukin 23, interferon-gamma and lipoxin A4 to promote the resolution of allergic airway inflammation, Nat Immunol, 9, 873, 10.1038/ni.1627 · DOI · Paper page
  98. Barnig, 2013, Lipoxin A4 regulates natural killer cell and type 2 innate lymphoid cell activation in asthma, Sci Transl Med, 5, 174ra26, 10.1126/scitranslmed.3004812 · DOI · Paper page
  99. Doyle, 2014, Development of a membrane-anchored chemerin receptor agonist as a novel modulator of allergic airway inflammation and neuropathic pain, J Biol Chem, 289, 13385, 10.1074/jbc.M113.522680 · DOI
  100. Levy, 2002, Multi-pronged inhibition of airway hyper-responsiveness and inflammation by lipoxin A(4), Nat Med, 8, 1018, 10.1038/nm748 · DOI · Paper page
  101. Levy, 2007, Lipoxin A4 stable analogs reduce allergic airway responses via mechanisms distinct from CysLT1 receptor antagonism, FASEB J, 21, 3877, 10.1096/fj.07-8653com · DOI
  102. Sanak, 2000, Aspirin-tolerant asthmatics generate more lipoxins than aspirin-intolerant asthmatics, Eur Respir J, 16, 44, 10.1034/j.1399-3003.2000.16a08.x · DOI · Paper page
  103. Yamaguchi, 2011, Urinary concentrations of 15-epimer of lipoxin A(4) are lower in patients with aspirin-intolerant compared with aspirin-tolerant asthma, Clin Exp Allergy, 41, 1711, 10.1111/j.1365-2222.2011.03839.x · DOI
  104. Hasan, 2012, Lipoxin A(4) and 8-isoprostane in the exhaled breath condensate of children hospitalized for status asthmaticus, Pediatr Crit Care Med, 13, 141, 10.1097/PCC.0b013e3182231644 · DOI
  105. Tahan, 2008, The role of lipoxin A4 in exercise-induced bronchoconstriction in asthma, J Asthma, 45, 161, 10.1080/02770900701847068 · DOI

Cited by

See all 235

Metadata

Authors
Miyata, J., & Arita, M.
Venue
Allergology International
Publisher
Elsevier BV
Published
2015-01
Volume
64
Issue
1
Pages
27-34
ISSN
1323-8930 (ISSN-L)
OpenAlex
W2110465069
Cited by
235
References
7
FWCI
8.39
Type
journal article
Language
en
Open access
gold
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Role of omega-3 fatty acids and their metabolites in asthma and allergic diseases. https://app.cochat.ai/papers/10.1016/j.alit.2014.08.003
The paper
Miyata, J., & Arita, M. (2015). Role of omega-3 fatty acids and their metabolites in asthma and allergic diseases. Allergology International. https://doi.org/10.1016/j.alit.2014.08.003

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.